論文- 藤村 卓 -
表示方法: 表示形式: 表示順:
件数:196件
[2019]
1.Japanese Dermatological Association Guidelines: Outlines of guidelines for cutaneous melanoma 2019..[The Journal of dermatology,(2019)]Nakamura Y, Asai J, Igaki H, Inozume T, Namikawa K, Hayashi A, Fukushima S, Fujimura T, Ito T, Imafuku K, Tanaka R, Teramoto Y, Minagawa A, Miyagawa T, Miyashita A, Wada M, Koga H, Sugaya M
10.1111/1346-8138.15151
http://www.ncbi.nlm.nih.gov/pubmed/31782186
2.Advanced Invasive Extramammary Paget's Disease Concomitant with Cecal Cancer Possessing Rare Variant of TP53 Single Nucleotide Polymorphism..[Case reports in oncology,12(3),(2019),855-860]Kambayashi Y, Fujimura T, Ohuchi K, Tono H, Ishida Y, Otsuka A, Aiba S
10.1159/000504339
http://www.ncbi.nlm.nih.gov/pubmed/31824279
3.Successful Treatment of Multiple Metastatic Melanoma with Nivolumab, Ipilimumab plus Denosumab Combined Therapy..[Case reports in oncology,12(3),(2019),829-833]Yoshida S, Fujimura T, Kambayashi Y, Amagai R, Hashimoto A, Aiba S
10.1159/000504019
http://www.ncbi.nlm.nih.gov/pubmed/31762756
4.Significance of BRAF Kinase Inhibitors for Melanoma Treatment: From Bench to Bedside..[Cancers,11(9),(2019)]Fujimura T, Fujisawa Y, Kambayashi Y, Aiba S
10.3390/cancers11091342
http://www.ncbi.nlm.nih.gov/pubmed/31514399
5.Variable indoleamine 2,3-dioxygenase expression in acral / mucosal melanoma and its possible link to immunotherapy..[Cancer science,110(11),(2019),3434-3441]Iga N, Otsuka A, Hirata M, Kataoka TR, Irie H, Nakashima C, Matsushita S, Uchi H, Yamamoto Y, Funakoshi T, Fujisawa Y, Yoshino K, Fujimura T, Hata H, Ishida Y, Kabashima K
10.1111/cas.14195
http://www.ncbi.nlm.nih.gov/pubmed/31509303
6.Perifolliculitis capitis abscedens et suffodiens treatment with tumor necrosis factor inhibitors: A case report and review of published cases..[The Journal of dermatology,46(9),(2019),802-807]Takahashi T, Yamasaki K, Terui H, Omori R, Tsuchiyama K, Fujimura T, Aiba S
10.1111/1346-8138.14998
http://www.ncbi.nlm.nih.gov/pubmed/31271451
7.A novel technique to diagnose non-melanoma skin cancer by thermal conductivity measurements: Correlations with cancer stromal factors..[Experimental dermatology,28(9),(2019),1029-1035]Fujimura T, Okabe T, Tanita K, Sato Y, Lyu C, Kambayashi Y, Maruyama S, Aiba S
10.1111/exd.13997
http://www.ncbi.nlm.nih.gov/pubmed/31264287
8.Malassezia-derived aryl hydrocarbon receptor ligands enhance the CCL20/Th17/soluble CD163 pathogenic axis in extra-mammary Paget's disease..[Experimental dermatology,28(8),(2019),933-939]Sato Y, Fujimura T, Tanita K, Chunbing L, Matsushita S, Fujisawa Y, Otsuka A, Yamamoto Y, Hidaka T, Aiba S
10.1111/exd.13944
http://www.ncbi.nlm.nih.gov/pubmed/31001887
9.Successful treatment of unresectable recurrent programmed death ligand 1 moderately-expressing malignant melanoma of the nasal cavity with pembrolizumab monotherapy..[The Journal of dermatology,46(7),(2019),e260-]Fujimura T, Kambayashi Y, Sato Y, Tanita K, Tono H, Lyu C, Takahashi T, Hashimoto A, Aiba S
10.1111/1346-8138.14786
http://www.ncbi.nlm.nih.gov/pubmed/30672615
10.Severe rhabdomyolysis developing in an advanced melanoma patient treated by pembrolizumab followed by dabrafenib trametinib combined therapy..[The Journal of dermatology,46(7),(2019),e256-e258]Irimada M, Fujimura T, Kambayashi Y, Tsukada A, Takahashi T, Hashimoto A, Aiba S
10.1111/1346-8138.14778
http://www.ncbi.nlm.nih.gov/pubmed/30656733
11.Successful treatment of microcystic adnexal carcinoma on the philtrum with oral S-1 monotherapy..[The Journal of dermatology,46(6),(2019),e208-e209]Haga T, Fujimura T, Aiba S
10.1111/1346-8138.14770
http://www.ncbi.nlm.nih.gov/pubmed/30663155
12.Lichen planus pemphigoides developing from patient with non-small-cell lung cancer treated with nivolumab..[The Journal of dermatology,46(10),(2019),e374-e375]Sato Y, Fujimura T, Mizuashi M, Aiba S
10.1111/1346-8138.14906
http://www.ncbi.nlm.nih.gov/pubmed/31062404
13.Successful treatment of multiple eruptive adult xanthogranuloma concomitant with xanthelasma palpebrarum with probucol..[The Journal of dermatology,46(10),(2019),e362-e364]Ishihara-Yusa S, Fujimura T, Lyu C, Sugawara M, Sakamoto K, Aiba S
10.1111/1346-8138.14903
http://www.ncbi.nlm.nih.gov/pubmed/31050040
14.Classification of 3097 patients from the Japanese melanoma study database using the American joint committee on cancer eighth edition cancer staging system..[Journal of dermatological science,94(2),(2019),284-289]Yasuhiro Fujisawa, Shusuke Yoshikawa, Akane Minagawa, Tatsuya Takenouchi, Kenji Yokota, Hiroshi Uchi, Naoki Noma, Yasuhiro Nakamura, Jun Asai, Junji Kato, Susumu Fujiwara, Satoshi Fukushima, Jiro Uehara, Toshihiko Hoashi, Tatsuya Kaji, Taku Fujimura, Kenjiro Namikawa, Manabu Yoshioka, Naoki Murata, Dai Ogata, Kanako Matsuyama, Naohito Hatta, Yoshitsugu Shibayama, Toshiharu Fujiyama, Masashi Ishikawa, Daisuke Yamada, Akiko Kishi, Yoshiyuki Nakamura, Takatoshi Shimiauchi, Kazuyasu Fujii, Manabu Fujimoto, Hironobu Ihn, Norito Katoh
10.1016/j.jdermsci.2019.04.003
http://www.ncbi.nlm.nih.gov/pubmed/31023613
15.Clinical and histopathological characteristics and survival analysis of 4594 Japanese patients with melanoma..[Cancer medicine,8(5),(2019),2146-2156]Yasuhiro Fujisawa, Shusuke Yoshikawa, Akane Minagawa, Tatsuya Takenouchi, Kenji Yokota, Hiroshi Uchi, Naoki Noma, Yasuhiro Nakamura, Jun Asai, Junji Kato, Susumu Fujiwara, Satoshi Fukushima, Jiro Uehara, Toshihiko Hoashi, Tatsuya Kaji, Taku Fujimura, Kenjiro Namikawa, Manabu Yoshioka, Naoki Murao, Dai Ogata, Kanako Matsuyama, Naohito Hatta, Yoshitsugu Shibayama, Toshiharu Fujiyama, Masashi Ishikawa, Daisuke Yamada, Akiko Kishi, Yoshiyuki Nakamura, Takatoshi Shimiauchi, Kazuyasu Fujii, Manabu Fujimoto, Hironobu Ihn, Norito Katoh
10.1002/cam4.2110
http://www.ncbi.nlm.nih.gov/pubmed/30932370
16.Three cases of nivolumab therapy-failed advanced melanoma successfully controlled by ipilimumab with intensity-modulated radiotherapy..[The Journal of dermatology,46(5),(2019),449-452]Amagai R, Fujimura T, Kambayashi Y, Sato Y, Tanita K, Hashimoto A, Aiba S
10.1111/1346-8138.14861
http://www.ncbi.nlm.nih.gov/pubmed/30908705
17.First-in-human clinical study of novel technique to diagnose malignant melanoma via thermal conductivity measurements..[Scientific reports,9(1),(2019),3853-]Okabe T, Fujimura T, Okajima J, Kambayashi Y, Aiba S, Maruyama S
10.1038/s41598-019-40444-6
http://www.ncbi.nlm.nih.gov/pubmed/30846837
18.Pembrolizumab resolves adult ashy dermatosis developing in patients with squamous cell carcinoma of the lung..[The Journal of dermatology,46(3),(2019),271-273]Takeda K, Fujimura T, Tsuchiyama K, Lyu C, Aiba S
10.1111/1346-8138.14775
http://www.ncbi.nlm.nih.gov/pubmed/30663147
19.Bexarotene Reduces Production of CCL22 From Tumor-Associated Macrophages in Cutaneous T-Cell Lymphoma..[Frontiers in oncology,9,(2019),907-]Tanita K, Fujimura T, Sato Y, Lyu C, Kambayashi Y, Ogata D, Fukushima S, Miyashita A, Nakajima H, Nakamura M, Morita A, Aiba S
10.3389/fonc.2019.00907
http://www.ncbi.nlm.nih.gov/pubmed/31616630
20.Accumulation of exhausted CD8+ T cells in extramammary Paget's disease..[PloS one,14(1),(2019),e0211135-]Iga N, Otsuka A, Yamamoto Y, Nakashima C, Honda T, Kitoh A, Nakajima S, Egawa G, Nomura T, Dainichi T, Matsushita S, Tanizaki H, Yamamoto Y, Funakoshi T, Fujisawa Y, Fujimura T, Hata H, Ishida Y, Kabashima K
10.1371/journal.pone.0211135
http://www.ncbi.nlm.nih.gov/pubmed/30682105
Page: [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [next]
戻るこのページのトップへ
copyright(c)2005 Tohoku University